We are live on ! Find out more
OPTN

OptiNose

Delisted

OPTN was delisted on the 20th of May, 2025.

64 hedge funds and large institutions have $271M invested in OptiNose in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 16

87% more capital invested

Capital invested by funds: $144M → $271M (+$126M)

0.45% more ownership

Funds ownership: 3.8%4.25% (+0.45%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less funds holding

Funds holding: 6764 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
64
Holders Change
-3
Holders Change %
-4.48%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
30
Reduced
16
Closed
7
Calls
Puts
Net Calls
Net Calls Change

OPTN Hedge Fund Activity: Q1 2019 in Review

64 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q1 2019, worth a combined $271M — up 87% from $144M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of OPTN and 4 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 30 added.

The largest buyer was SVB Wealth, opening a new position worth an estimated $15.3M. The largest seller was Tamarack Advisers, exiting entirely with an estimated $1.86M sold.

  • 64 institutional investors held OptiNose (OPTN) as of Q1 2019, down from 67 in Q4 2018.
  • Funds reported $271M of OptiNose stock for Q1 2019, up 87% quarter-over-quarter.
  • 4 funds opened new OptiNose positions in Q1 2019 and 7 closed out, a net change of -3 holders.
  • The largest OptiNose buyer in Q1 2019 was SVB Wealth, an estimated $15.3M added.
  • The largest OptiNose seller in Q1 2019 was Tamarack Advisers, an estimated $1.86M sold.

Based on aggregated 13F filings for Q1 2019.